Welcome to our dedicated page for Protext Mobility news (Ticker: TXTM), a resource for investors and traders seeking the latest updates and insights on Protext Mobility stock.
Protext Mobility, Inc. (OTC: TXTM) generates frequent news as it develops plant-based therapeutics and highly bioavailable botanical formulations using proprietary live plant extraction and nanotechnology-based methods. Company announcements highlight its work with Genus Cannabis Sativa, CBD-rich applications, and broader botanical research for nutraceutical and pharmaceutical uses.
On this page, readers can follow TXTM news related to research and testing updates, supply and seed inventory disclosures, and developments in its live plant extraction technology. Protext’s releases also cover strategic relationships, such as its Letter of Intent with TruLeaf, which the company describes as providing product samples, initial inventory allocations, infrastructure support, and other resources intended to support operational readiness and early-stage commercial development.
Investors and observers can review news about Protext’s approach to treating active pharmaceutical ingredients and other plant-based assets as real-world assets, its discussion of potential tokenization of these assets, and its stated interest in stablecoin and other financial applications linked to CBD-based APIs. The company’s communications further address foreign exchange effects on seed inventory, seed multiplication programs, and its stated zero-waste, green, circular economy model.
Additional TXTM news items include updates on Advisory Board appointments, such as the addition of international advisors, and initiatives focused on transparency and governance, including investor relations presentations, voluntary EDGAR filings, and OTC Markets status changes. This news feed offers a centralized view of Protext’s public statements about its plant-based biotechnology activities, strategic partnerships, and evolving corporate roadmap.
Summary not available.
Protext Mobility (OTC PINK: TXTM) announced that a caveat emptor designation was placed on its trading symbol by OTCMarkets on November 11, 2022. Management is actively working to resolve this issue with the assistance of SEC legal counsel. They assure shareholders that the company's fundamentals remain strong and are committed to the Protext mission. Updates will be communicated through official channels. The company emphasizes confidence in overcoming this uncertainty and positioning itself favorably for the future.
Protext Mobility (OTC PINK: TXTM) has announced a significant initial order of 2.33 million pounds of Genus Cannabis Sativa, marking a milestone in cannabis supply agreements. This is touted as possibly the largest single cannabis order post-legalization, primarily for the Charlottes Angel strain, known for its high CBD content. The company, operating under federal permits in South Africa, plans to launch a branded CBD product line and aims to commercialize innovative live plant extraction technologies that enhance bioavailability by 10-15 times. This positions Protext as a leader in global hemp production.
Protext Mobility (OTC PINK: TXTM) has made significant progress in commercializing its proprietary live plant extraction technology. Following successful negotiations, the company has regained use of the Kettle extraction equipment, now located at Dr. Hurley's laboratory. This technology, which has demonstrated 10-15 times greater bioavailability than current products, is expected to revolutionize the cannabis market by producing potent, non-psychoactive extracts. TXTM anticipates exponential profit growth and is now positioned closer than ever to commercialization.
Protext Mobility, Inc. (OTC PINK: TXTM) has announced a Letter of Intent to acquire 100% of a top-shelf vodka brand, comprising three companies focused on brand assets, distribution, and licensing. The vodka is notable for being odorless and nine times distilled from premium French grain. The acquisition will be finalized within two weeks in exchange for preferred stock. CEO David Lewis emphasized the continuity of the new management and potential synergies with Protext's existing cannabis extraction technology, hinting at a roadmap for further development in North America.